PUBLISHER: The Business Research Company | PRODUCT CODE: 1946731
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946731
A pediatric and neonatal testing kit encompasses a compilation of specialized medical devices, instruments, and tools meticulously crafted for the evaluation and diagnosis of infants, newborns, and children. These kits serve as indispensable resources for healthcare professionals, including pediatricians, neonatologists, nurses, and other medical personnel, facilitating the precise diagnosis, monitoring, and treatment of pediatric patients.
Key test types featured in pediatric and neonatal testing kits include dried blood spot, hearing screening, critical congenital heart defect (CCHD), among others. The dried blood spot (DBS) test, a diagnostic technique, entails the collection of a small blood volume from individuals, allowing it to dry on a specialized filter paper. The product offerings include assay kits, reagents, and instruments employing various cutting-edge technologies such as tandem mass spectrometry, pulse oximetry, enzyme-based assays, DNA-based assays, electrophoresis, and more. These advanced testing solutions cater to a diverse range of end users, including hospitals, diagnostic centers, maternity facilities, specialty clinics, and other healthcare institutions.
Tariffs are impacting the pediatric and neonatal testing kit market by increasing costs of imported reagents, assay components, diagnostic instruments, sensors, and consumables. Hospitals and diagnostic centers in North America and Europe are most affected due to reliance on imported testing supplies, while Asia-Pacific faces pricing pressure on kit manufacturing and exports. These tariffs are raising testing costs and affecting procurement budgets. However, they are also supporting domestic production of diagnostic kits, regional reagent manufacturing, and increased investment in localized testing infrastructure.
The pediatric and neonatal testing kit market research report is one of a series of new reports from The Business Research Company that provides pediatric and neonatal testing kit market statistics, including pediatric and neonatal testing kit industry global market size, regional shares, competitors with a pediatric and neonatal testing kit market share, detailed pediatric and neonatal testing kit market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric and neonatal testing kit industry. This pediatric and neonatal testing kit market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pediatric and neonatal testing kit market size has grown strongly in recent years. It will grow from $4.18 billion in 2025 to $4.55 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to expansion of neonatal screening initiatives, rising awareness of congenital disorders, improvements in diagnostic assay technologies, growth of pediatric healthcare infrastructure, increased hospital-based testing adoption.
The pediatric and neonatal testing kit market size is expected to see strong growth in the next few years. It will grow to $6.59 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to expansion of precision pediatric diagnostics, rising investments in newborn health programs, growing adoption of molecular diagnostic technologies, increasing demand for rapid and portable testing kits, integration of digital health monitoring. Major trends in the forecast period include increasing adoption of point-of-care pediatric testing kits, rising use of dried blood spot screening, growing integration of genetic and metabolic testing, expansion of newborn screening programs, enhanced focus on early disease detection.
The growing neonatal and pediatric population is fueling the expansion of the pediatric and neonatal testing kit market. Neonates refer to newborns, typically from birth to 28 days old, while pediatric patients include children and infants aged 21 or younger at the time of diagnosis or treatment. The pediatric and neonatal testing kit market is essential for meeting the specific healthcare needs of this increasing population. For instance, in October 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, a total of 292,318 births were registered in Australia in 2024, reflecting a 1.9% increase (an additional 5,320 births) compared to 2023, with 150,299 male and 142,019 female babies. Therefore, the rising neonatal and pediatric population is driving growth in the pediatric and neonatal testing kits market.
Major companies operating in the pediatric and neonatal testing market are focusing on developing advanced solutions, such as mass screening tests, to enhance early detection, reduce diagnostic delays, and improve treatment outcomes for newborns. Mass screening tests refer to diagnostic kits designed to identify serious conditions in newborns shortly after birth, enabling prompt medical intervention. For instance, in May 2024, Shimadzu Techno-Research, Inc., a Japan-based contract analysis company, launched a new contract service to conduct PCR testing for enhanced newborn mass screening. The service provides testing for severe rare diseases, including Severe Combined Immunodeficiency (SCID), B-cell Deficiency (BCD), and Spinal Muscular Atrophy (SMA), and is currently offered in 40 out of Japan's 47 prefectures, with plans to expand nationwide through public funding. By partnering with hospitals and delivery facilities, the service aims to improve the health and welfare of newborns throughout Japan.
In March 2025, LaCAR MDx Technologies, a Belgium-based molecular diagnostics company, acquired the Newborn Screening Division of Baebies, Inc. for an undisclosed amount. Through this acquisition, LaCAR MDx aims to expand its pediatric and neonatal testing capabilities by integrating Baebies' expertise in newborn screening and enhancing its portfolio of diagnostic tests for early detection of congenital disorders. Baebies, Inc. is a US-based company that provides pediatric and neonatal testing kits, including screening for metabolic, endocrine, and genetic conditions.
Major companies operating in the pediatric and neonatal testing kit market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic Plc, Siemens Healthineers, GE Healthcare GmbH, Eurofins Scientific SE, Trivitron Healthcare Pvt Ltd., Hologic Inc., PerkinElmer Inc., Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Natus Medical Incorporated, BioFire Diagnostics LLC, Luminex Corporation, Meridian Bioscience Inc., MP Biomedicals LLC, ELITech Group SAS, Baebies Inc., Labsystems Diagnostics Oy, Beckman Coulter Inc., JETA Molecular BV, ZenTech SA, Hangzhou Testsea Biotechnology Co. Ltd.
North America was the largest region in the pediatric and neonatal testing kit market in 2025. The regions covered in the pediatric and neonatal testing kit market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pediatric and neonatal testing kit market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pediatric and neonatal testing kit market consists of sales of maternal blood screening, ultrasound tests, amniocentesis, and glucose screening. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pediatric And Neonatal Testing Kit Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pediatric and neonatal testing kit market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pediatric and neonatal testing kit ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pediatric and neonatal testing kit market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.